A new approach for membrane modification based on electrochemically mediated living polymerization and self-assembly of N-tert-butyl amide- and β-cyclodextrin-involved macromolecules for blood purification

Poloxamer 407 Combined with Polyvinylpyrrolidone To Prepare a High-Performance Poly(ether sulfone) Ultrafiltration Membrane

At present, the design and fabrication of polymer membranes with high permeability and good retention ability are still huge challenges. In this study, the commercial Poloxamer 407 (Pluronic F127) is selected as a multifunctional additive, and polyvinylpyrrolidone is used as a pore-forming agent to modify the poly(ether sulfone) membrane by liquid-liquid phase conversion technology to prepare an ultrafiltration membrane with excellent performance. The hydrophobic poly(propylene oxide) segment in Poloxamer 407 guarantees that this copolymer can be firmly anchored to the poly(ether sulfone) matrix, and the hydrophilic poly(ethylene oxide) segments in Poloxamer 407 impart a stronger hydrophilic nature to the modified membrane surface. Therefore, the permeability and hydrophilicity of the modified membrane are significantly improved and the modified membrane also has good stability. When the amount of Poloxamer 407 added to the casting solution reached 0.6 g, the water flux of the modified membrane was as high as 368 L m-2 h-1, and the rejection rate of bovine serum albumin was close to 98%. In the test to isolate organic small molecule dyes, the retention rate of the modified membrane to Congo red is 94.27%. In addition, the modified membrane shows an excellent water flux recovery rate and antifouling ability. It performs well in subsequent cycle tests and long-term membrane life tests and can be used repeatedly. Our work has resulted in poly(ether sulfone) membranes with good performance, which show great potential in the treatment of biomedical wastewater and the removal of industrial organic dye wastewater, it provides ideas for the development and application of amphiphilic polymer materials.

Construction of an Antithrombotic and Anti-Inflammatory Polyethersulfone Membrane

In addition to being the core factor in thrombosis, thrombin is involved in various inflammatory disease responses, but few studies have examined whether and how it is involved in membrane-related inflammation. In this study, the thrombin inhibitor dabigatran is used to modify a polyethersulfone dialysis membrane. The modified membrane shows good hydrophilic properties and dialysis performance. It reduces the thrombin level in a targeted manner, thereby significantly inhibiting coagulation factor activation (based on the prothrombin time, international normalized ratio, activated partial thromboplastin time and thrombin time) and reducing the fibrinogen level and platelet adhesion. On thromboelastography, it shows excellent dynamic antithrombotic capacity. The modified membrane inhibited membrane-related inflammation by inhibiting the production of the inflammatory mediators C-reactive protein (CRP), interleukin-6 (IL-6), and interleukin-1β (IL-1β) via the thrombin/complement C5a pathway. Moreover, it is found to be safe in an in vivo study. Thus, the dabigatran-modified polyethersulfone membrane may reduce dialysis-related complications through its dual antithrombotic and anti-inflammatory effects.

A review on surface modification methods of poly(arylsulfone) membranes for biomedical applications

Considerable methods have so far been used for the surface modification of biomedical membranes. Several reviews and articles have been published on the improvements achieved in the field of poly(arylsulfone) membranes subjected to various surface modification methods and used in biomedical applications. This review concentrates on the surface modification, biological applications and future perspective of the poly(arylsulfone) biomedical membranes. Different surface modification procedures employed for the poly(arylsulfone) membranes have been classified, studied and compared. Diverse surface modification techniques include surface coating, chemical modification and immobilization/cross-linking, grafting, surface zwitterionicalization, mussel-inspired coating and layer-by-layer assembly. Furthermore, we review the recent research studies performed on the surface modification of the poly(arylsulfone) biomedical membranes. Meanwhile, the properties of biomedical membranes are also discussed in each section. At last, the future perspective and challenges of the strategies utilized for the surface modification of poly(arylsulfone) biomedical membranes are presented.

Modification of a polyethersulfone membrane with a block copolymer brush of poly(2-methacryloyloxyethyl phosphorylcholine-co-glycidyl methacrylate) and a branched polypeptide chain of Arg–Glu–Asp–Val

Polyethersulfone (PES) has good thermal stability, superior pH, chlorine tolerance, and excellent chemical resistance; however, the hydrophilicity and biocompatibility of PES need to be improved for its real applications. In this study, we report a surface modification method for the preparation of a functional PES membrane with hydrophilic polymer chains (MPC and GMA) via surface-initiated electrochemically-mediated atom-transfer radical polymerization (SI-eATRP) technology, and the Arg–Glu–Asp–Val polypeptide groups (REDV) were immobilized onto the modified membrane by a ring-opening reaction. XPS and SEM were used to analyze the chemical composition and morphology of the modified membrane surfaces, confirming that the hydrophilic polymer chains MPC and GMA and the polypeptide group REDV were successfully grafted onto the PES membrane surface. The static water contact angle decreased from 89° to 50–65°, and the hydrophilic property of the modified membrane was enhanced. The water flux increased from 4.29 L m⁻² h⁻¹ for the pristine PES membrane to 25 L m⁻² h⁻¹ for the modified membrane with PGMA chains grafted on it and REDV functional groups immobilized on it; note that the antifouling tests showed that all the modified membranes had the higher flux recovery ratio values (FRR) of above 80% than the pristine PES membrane (about 60%), and the APTT for the modified membrane increased from 46 s to 93 s, indicating that these modified membranes could be applied in the separation and blood purification fields.

A block copolymer involving chains of poly(2-methacryloyloxyethyl phosphorylcholine-co-glycidyl methacrylate) and Arg–Glu–Asp–Val was designed and used for modification of polymer membrane for applications in separation and blood purification field.